Kevin N. Heller - 24 Sep 2021 Form 3 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
EVP, Research and Development
Signature
By: /s/ Jeet Mahal, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
24 Sep 2021
Net transactions value
$0
Form type
3
Filing time
01 Oct 2021, 16:10:57 UTC
Next filing
23 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JSPR Stock Option (right to buy) 24 Sep 2021 Common Stock 657,769 $0.7100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares subject to the option vested on August 10, 2021, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney